CM

Cheryl Maley

Starpharma Holdings Limited | Chief Executive Officer, Managing Director
Mrs Maley has pharmaceutical industry experience in range of therapeutic areas, including oncology, womens health, infectious diseases, immunology, cardiology, gastroenterology, dermatology and neuroscience. She has worked with GP, specialist, and hospital products and has experience as a commercial leader on global product development teams. Cheryl began her career in research at CSIRO before moving into sales and marketing roles at Servier Laboratories, Lederle Laboratories, and Wyeth Pharmaceuticals. She then moved into several leadership positions in business development, sales and marketing at Abbott Australia and, later, Abbott International. Her roles included Director of the Specialty Products Division in Australia, Director of the Global Strategic Initiatives, Immunology, in the US, and Director of Commercial Excellence During her nine-year career at Novartis, Cheryl held several senior leadership positions. Cheryl was Country Head and President of Novartis Philippines. Cheryl has most recently been serving as the Acting CEO and Strategic Advisor at Biointelect. Currently, Cheryl is also a Non-Executive Director of Clarity Pharmaceuticals (ASX:CU6).

Companies and Roles

Company
Title
Tenure
Since
SPL
Starpharma Holdings Limited
  • Chief Executive Officer
  • Managing Director
4mthJan 2024
CU6
Clarity Pharmaceuticals Ltd
  • Non-Executive Director
1yrs, 3mthFeb 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
SPL
Starpharma Holdings Limited
08/01/24N/AN/AN/AN/A
CU6
Clarity Pharmaceuticals Ltd
01/02/230N/AN/AN/A